Regeneron Pharmaceuticals, Inc. (REGN)

Growth

Revenue 5Y26.33%
Revenue 3Y33.92%
EPS 5Y54.40%
EPS 3Y49.07%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC25.13%
ROE26.58%
ROA19.40%
ROTA19.40%

Capital Structure

Market Cap80.72B
EV79.93B
Cash3.49B
Current Ratio5.36
Debt/Equity0.23
Net Debt/EBITDA-0.12
Show More

Income Statement

Select a metric from the list below to chart it

Dec '90
Dec '96
Dec '02
Dec '08
Dec '14
Dec '20
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
2,104.7
2,819.6
4,103.7
4,860.4
5,872.2
6,710.8
7,863.4
8,497.1
16,071.7
13,710.2
Revenue % Chg.
52.7%
34.0%
45.5%
18.4%
20.8%
14.3%
17.2%
8.1%
89.1%
1.2%
Cost of Revenue
155.4
205.0
392.7
299.7
397.1
434.1
782.2
1,119.9
2,437.5
2,002.4
Cost of Revenue % Chg.
84.0%
32.0%
91.5%
-23.7%
32.5%
9.3%
80.2%
43.2%
117.7%
10.8%
Gross Profit
1,949.4
2,614.5
3,711.0
4,560.7
5,475.2
6,276.7
7,081.2
7,377.2
13,634.2
11,707.8
Gross Profit % Chg.
50.6%
34.1%
41.9%
22.9%
20.1%
14.6%
12.8%
4.2%
84.8%
-0.2%
Gross Profit Margin
92.6%
92.7%
90.4%
93.8%
93.2%
93.5%
90.1%
86.8%
84.8%
85.4%
Gross Profit Margin % Chg.
-1.3%
0.1%
-2.5%
3.8%
-0.6%
0.3%
-3.7%
-3.6%
-2.3%
-1.4%
R&D Expenses
859.9
1,271.4
1,620.6
2,052.3
2,075.1
2,186.1
3,036.6
2,735.0
2,908.1
3,335.0
R&D Expenses % Chg.
37.5%
47.8%
27.5%
26.6%
1.1%
5.3%
38.9%
-9.9%
6.3%
16.3%
Selling, General, & Admin Expenses
329.4
504.8
838.5
1,177.7
1,320.4
1,556.2
1,834.8
1,346.0
1,824.9
2,015.0
Selling, General, & Admin Expenses % Chg.
56.3%
53.2%
66.1%
40.4%
12.1%
17.9%
17.9%
-26.6%
35.6%
28.4%
Other Expenses
-
-
-
-
-
-
-
-280.4
-45.6
-99.1
Other Expenses % Chg.
-
-
-
-
-
-
-
-
83.7%
43.4%
Operating Income
760.0
838.4
1,251.9
1,330.7
2,079.6
2,534.4
2,209.8
3,576.6
8,946.8
6,231.8
Operating Income % Chg.
66.0%
10.3%
49.3%
6.3%
56.3%
21.9%
-12.8%
61.9%
150.1%
-16.6%
Operating Income Margin
36.1%
29.7%
30.5%
27.4%
35.4%
37.8%
28.1%
42.1%
55.7%
45.5%
Operating Income Margin % Chg.
8.8%
-17.7%
2.6%
-10.3%
29.3%
6.6%
-25.6%
49.8%
32.3%
-17.6%
Total Other Income/Expenses Net
-46.7
-62.7
-26.8
-0.9
-1.1
19.1
219.3
233.8
379.0
-194.3
Total Other Income/Expenses Net % Chg.
7.8%
34.3%
57.2%
96.5%
16.6%
-
1048.2%
6.6%
62.1%
-
Income Before Tax
713.4
775.7
1,225.1
1,329.8
2,078.5
2,553.5
2,429.1
3,810.4
9,325.8
6,037.5
Income Before Tax % Chg.
72.1%
8.7%
57.9%
8.5%
56.3%
22.9%
-4.9%
56.9%
144.7%
-25.0%
Income Before Tax Margin
33.9%
27.5%
29.9%
27.4%
35.4%
38.1%
30.9%
44.8%
58.0%
44.0%
Income Before Tax Margin % Chg.
12.7%
-18.8%
8.5%
-8.4%
29.4%
7.5%
-18.8%
45.2%
29.4%
-25.9%
Income Tax Expense
289.0
427.7
589.0
434.3
880.0
109.1
313.3
297.2
1,250.5
667.2
Income Tax Expense % Chg.
-
48.0%
37.7%
-26.3%
102.6%
-87.6%
187.2%
-5.1%
320.8%
-36.5%
Net Income
424.4
348.1
636.1
895.5
1,198.5
2,444.4
2,115.8
3,513.2
8,075.3
5,370.3
Net Income % Chg.
-43.4%
-18.0%
82.7%
40.8%
33.8%
104.0%
-13.4%
66.0%
129.9%
-23.2%
Net Income Margin
20.2%
12.3%
15.5%
18.4%
20.4%
36.4%
26.9%
41.3%
50.2%
39.2%
Net Income Margin % Chg.
-63.0%
-38.8%
25.6%
18.9%
10.8%
78.5%
-26.1%
53.7%
21.5%
-24.2%
Weighted Avg. Shares Out
97.9
100.6
103.1
104.7
106.3
107.9
109.2
107.6
107.6
107.0
Weighted Avg. Shares Out % Chg.
3.4%
2.8%
2.4%
1.6%
1.5%
1.5%
1.2%
-1.5%
-
1.4%
EPS
4.3
3.5
6.2
8.6
11.3
22.7
19.4
32.7
76.4
50.3
EPS % Chg.
-45.3%
-20.1%
78.3%
38.6%
31.8%
101.0%
-14.4%
68.5%
134.0%
-24.2%
Weighted Avg. Shares Out Dil
111.3
113.4
115.2
116.4
116.0
114.8
114.6
115.1
115.1
113.3
Weighted Avg. Shares Out Dil % Chg.
-3.5%
1.9%
1.6%
1.0%
-0.4%
-1.0%
-0.2%
0.4%
-
1.3%
EPS Diluted
3.8
3.1
5.5
7.7
10.3
21.3
18.5
30.5
72.0
47.4
EPS Diluted % Chg.
-43.6%
-19.4%
79.8%
39.5%
34.3%
105.9%
-13.3%
65.3%
135.8%
-24.3%
Interest Expense
46.4
37.4
14.2
7.2
25.1
28.2
30.2
56.9
57.3
56.1
Interest Expense % Chg.
2.5%
-19.5%
-61.9%
-49.5%
249.1%
12.3%
7.1%
88.4%
0.7%
-3.3%
EBIT
666.9
738.4
1,210.9
1,322.6
2,053.4
2,525.3
2,398.9
3,753.5
9,268.5
5,981.4
EBIT % Chg.
80.7%
10.7%
64.0%
9.2%
55.3%
23.0%
-5.0%
56.5%
146.9%
-25.1%
EBIT Margin
31.7%
26.2%
29.5%
27.2%
35.0%
37.6%
30.5%
44.2%
57.7%
43.6%
EBIT Margin % Chg.
18.3%
-17.4%
12.7%
-7.8%
28.5%
7.6%
-18.9%
44.8%
30.6%
-26.0%
Depreciation & Amortization
41.2
52.7
74.9
104.7
145.5
148.2
210.3
235.9
286.2
315.8
Depreciation & Amortization % Chg.
11.5%
27.9%
42.2%
39.8%
38.9%
1.9%
41.9%
12.2%
21.3%
15.5%
EBITDA
708.1
791.1
1,285.8
1,427.4
2,198.9
2,673.5
2,609.2
3,989.4
9,554.7
6,297.2
EBITDA % Chg.
74.4%
11.7%
62.5%
11.0%
54.1%
21.6%
-2.4%
52.9%
139.5%
-23.8%
EBITDA Margin
33.6%
28.1%
31.3%
29.4%
37.4%
39.8%
33.2%
47.0%
59.5%
45.9%
EBITDA Margin % Chg.
14.2%
-16.6%
11.7%
-6.3%
27.5%
6.4%
-16.7%
41.5%
26.6%
-24.7%